Goldman, J. W., Piha-Paul, S. A., Curti, B., Pedersen, K. S., Bauer, T. M., Groenland, S. L., Carvajal, R. D., Chhaya, V., Kirby, G., McGlinchey, K., Hammond, S. A., Streicher, K., Townsley, D. M., Chae, Y. K., Voortman, J., Marabelle, A., & Powderly, J. (2022). Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research, 28(17), 3709–3719. https://doi.org/10.1158/1078-0432.ccr-21-3016